Stocktoria

PRECISION OPTICS CORPORATION, INC. POCI

Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
3/9
Piotroski F — financial health
-8.27
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$19.1M-$5.8M$3.4M-$3.8M$12.3M
2024$19.1M-$3.0M$5.8M-$3.0M$10.1M
2023$21.0M-$144,613$7.7M-$97,874$12.0M
2022$15.7M-$928,416$4.9M-$1.0M$9.0M
2021$10.7M-$102,835$3.4M-$29,374$3.4M
2020$9.9M-$1.4M$3.4M-$711,642$2.8M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
COLL WAYNE MChief Financial Officer2026-03-31Grant1,568$3.98
COLL WAYNE MChief Financial Officer2026-03-30Buy20,833$3.60
Forkey Joseph NormanChief Executive Officer2026-03-30Buy1,388$3.60
TRAUT JOSEPHChief Operating Officer2026-03-30Buy41,666$3.60
Miclot Andrew J.director2026-03-12Tax withheld6,372$4.52
Miclot Andrew J.director2026-03-12Option exercise20,000$1.44
COLL WAYNE MChief Financial Officer2025-12-31Grant1,420$6,250.00
COLL WAYNE MChief Financial Officer2025-09-30Grant1,370$6,250.00

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -8.27 (distress)

  • Working capital / assets 0.197
  • Retained earnings / assets -2.879
  • EBIT / assets -0.281
  • Equity / liabilities 1.628

Source: SEC EDGAR filings · CIK 0000867840 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.